SEARLE & CO. - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 191 filers reported holding HERON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
SEARLE & CO. ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$87,808
-32.4%
85,250
+8.9%
0.03%
-25.0%
Q2 2023$129,895
-14.1%
78,250
+23.7%
0.04%
-18.4%
Q1 2023$151,168
+81.9%
63,250
+90.2%
0.05%
+75.0%
Q4 2022$83,125
-40.6%
33,2500.0%0.03%
-48.1%
Q3 2022$140,000
+50.5%
33,2500.0%0.05%
+45.9%
Q2 2022$93,000
-51.1%
33,2500.0%0.04%
-47.1%
Q1 2022$190,000
-56.4%
33,250
-30.4%
0.07%
-56.0%
Q4 2021$436,000
-14.5%
47,7500.0%0.16%
-23.9%
Q3 2021$510,000
-30.4%
47,750
+1.1%
0.21%
-30.3%
Q2 2021$733,000
+21.4%
47,250
+26.8%
0.30%
+11.5%
Q1 2021$604,000
-24.4%
37,250
-1.3%
0.27%
-29.9%
Q4 2020$799,000
+39.9%
37,750
-1.9%
0.38%
+23.5%
Q3 2020$571,000
+33.7%
38,500
+32.8%
0.31%
+25.4%
Q2 2020$427,000
+23.4%
29,000
-1.7%
0.25%
+1.2%
Q1 2020$346,000
+17.7%
29,500
+136.0%
0.24%
+51.2%
Q4 2019$294,000
+44.1%
12,500
+13.6%
0.16%
+35.0%
Q3 2019$204,000
-48.1%
11,000
-48.0%
0.12%
-49.8%
Q2 2019$393,000
+7.1%
21,150
-20.2%
0.24%
-5.2%
Q2 2017$367,000
+4.0%
26,500
+12.8%
0.25%
+1.6%
Q1 2017$353,00023,5000.25%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders